Wound Care Biologics Market worth $2.4 billion by 2027 - Exclusive Report by MarketsandMarkets™

News provided by

Jun 14, 2022, 11:00 ET

CHICAGO, June 14, 2022 /PRNewswire/ -- According to the new market research report "Wound Care Biologics Market by Product (Biological Skin Substitutes, Topical Agents), Wound Type (Ulcers [Diabetic Foot, Venous, Pressure Ulcers], Surgical & Traumatic Wounds, Burns), End User (Hospitals, ASCs, Burn Centers) – Global Forecast to 2027", published by MarketsandMarkets™, the Wound Care Biologics Market is valued at an estimated USD 1.8 billion in 2022 and is projected to reach USD 2.4 billion by 2027, at a CAGR of 5.4%.

Browse in-depth TOC on "Wound Care Biologics Market"
181 – Tables
33 – Figures
180 – Pages

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=259878425
the wound care biologics market is driven by the increasing prevalence of diabetes and growing number of surgical procedures and associated infections. Emerging economies such as China, Japan, and India are providing lucrative opportunities for the players operating in the market.

The ulcers segment accounted for the largest share of the wound care biologics market, by wound type segment, in 2021

Based on wound type, the wound care biologic market is segmented into ulcers, surgical & traumatic wounds, and burns. The ulcers segment accounted for the largest share of the wound care biologic market in 2021. Ulcers segment is further segmented into diabetic foot ulcers (DFUs), pressure ulcers, venous ulcers, and other ulcers. The diabetic foot ulcers segment accounted for the largest share of the market for ulcers in 2021. The key drivers for market growth are the growing patient pool for these conditions, the need for advanced technologies for treatment, and the lengthy healing process associated with these conditions.

Hospitals segment to register the highest growth rate during the forecast period

The wound care biologics market is segmented into hospitals, ambulatory surgery centers, and burn care centers & wound clinics. In 2021, hospitals segment accounted for the highest growth rate. The increasing number of severe burn cases and rising awareness about advanced burn care treatments are driving the growth of the hospitals segment.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=259878425

North America is the largest regional market for wound care biologics market

The global wound care biologic market has been segmented into five major regions—North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2021, North America accounted for the largest share of the market. The large share of this region can be attributed to the highly developed healthcare systems in the US and Canada. Growing healthcare expenditure is also one of the major drivers for the hospital sector in the region. This is considered a positive indicator of market growth, as hospitals are the major end users of wound care biologics products.

The major players operating in this wound care biologics market are are Smith & Nephew plc (UK), Organogenesis Inc. (US), MIMEDX (US), Integra LifeSciences (US), Stryker Corporation (US), Mölnlycke Health Care AB (Sweden), Vericel Corporation (US), Bioventus LLC (US), Anika Therapeutics, Inc. (US), and Kerecis (Iceland).

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=259878425

Browse Adjacent Markets: Medical Devices Market Research Reports & Consulting

Browse Related Reports:

Wound Care Market by Product (Dressings (Foam, Film, Hydrocolloid, Collagen, Alginate), Devices (NPWT, Debridement), Grafts, Matrices, Topical Agents, Sutures, Stapler), Wound (Traumatic, Diabetic Ulcers, Surgical, Burn), End User (2022 - 2026)
https://www.marketsandmarkets.com/Market-Reports/wound-care-market-371.html

Advanced Wound Care Market by Product (Dressings (Foam, Hydrocolloid, Film, Alginate), NPWT, Debridement Devices, Grafts, Matrices, Topical Agents), Wound Type (Surgical, Traumatic, Ulcers, Burns), End User (Hospital, Homecare) (2022 - 2026)
https://www.marketsandmarkets.com/Market-Reports/advanced-wound-care-market-88705076.html

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: [email protected]
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/wound-care-biologic-market.asp
Visit Our Web Site: https://www.marketsandmarkets.com
Content Source: https://www.marketsandmarkets.com/PressReleases/wound-care-biologic.asp